BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 21349701)

  • 1. Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway.
    Yue P; Gao ZH; Xue X; Cui SX; Zhao CR; Yuan Y; Yin Z; Inagaki Y; Kokudo N; Tang W; Qu XJ
    Eur J Cancer; 2011 May; 47(7):1115-24. PubMed ID: 21349701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.
    Guo K; Liu Y; Zhou H; Dai Z; Zhang J; Sun R; Chen J; Sun Q; Lu W; Kang X; Chen P
    Cancer Sci; 2008 Mar; 99(3):486-96. PubMed ID: 18167130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Des-gamma-carboxy prothrombin stimulates human vascular endothelial cell growth and migration.
    Wang SB; Cheng YN; Cui SX; Zhong JL; Ward SG; Sun LR; Chen MH; Kokudo N; Tang W; Qu XJ
    Clin Exp Metastasis; 2009; 26(5):469-77. PubMed ID: 19263229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells.
    Gao FJ; Cui SX; Chen MH; Cheng YN; Sun LR; Ward SG; Kokudo N; Tang W; Qu XJ
    Life Sci; 2008 Dec; 83(23-24):815-20. PubMed ID: 18976674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin.
    Ma M; Qu XJ; Mu GY; Chen MH; Cheng YN; Kokudo N; Tang W; Cui SX
    Chemotherapy; 2009; 55(1):28-35. PubMed ID: 18974646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-kappaB are involved in upregulation of matrix metalloproteinase-9 by tumour necrosis factor-alpha.
    Itatsu K; Sasaki M; Harada K; Yamaguchi J; Ikeda H; Sato Y; Ohta T; Sato H; Nagino M; Nimura Y; Nakanuma Y
    Liver Int; 2009 Feb; 29(2):291-8. PubMed ID: 18710428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
    Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
    Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of collagenase-3 (MMP-13) expression in transformed human keratinocytes by interferon-gamma is associated with activation of extracellular signal-regulated kinase-1,2 and STAT1.
    Ala-aho R; Johansson N; Grénman R; Fusenig NE; López-Otín C; Kähäri VM
    Oncogene; 2000 Jan; 19(2):248-57. PubMed ID: 10645003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma.
    Matsubara M; Shiraha H; Kataoka J; Iwamuro M; Horiguchi S; Nishina S; Takaoka N; Uemura M; Takaki A; Nakamura S; Kobayashi Y; Nouso K; Yamamoto K
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1602-8. PubMed ID: 22554292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA targeted against HAb18G/CD147 inhibits MMP-2 secretion, actin and FAK expression in hepatocellular carcinoma cell line via ERK1/2 pathway.
    Xu HY; Qian AR; Shang P; Xu J; Kong LM; Bian HJ; Chen ZN
    Cancer Lett; 2007 Mar; 247(2):336-44. PubMed ID: 16815629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
    Tang W; Miki K; Kokudo N; Sugawara Y; Imamura H; Minagawa M; Yuan LW; Ohnishi S; Makuuchi M
    Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cells.
    Hwang ES; Lee HJ
    Food Chem Toxicol; 2008 Jul; 46(7):2358-64. PubMed ID: 18502015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles and Signaling Pathways of Des-γ-Carboxyprothrombin in the Progression of Hepatocellular Carcinoma.
    Cui SX; Yu XF; Qu XJ
    Cancer Invest; 2016 Oct; 34(9):459-464. PubMed ID: 27673353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor (EGF) induces motility and upregulates MMP-9 and TIMP-1 in bovine trophoblast cells.
    Dilly M; Hambruch N; Haeger JD; Pfarrer C
    Mol Reprod Dev; 2010 Jul; 77(7):622-9. PubMed ID: 20578063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
    Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
    J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.
    Inagaki Y; Tang W; Makuuchi M; Hasegawa K; Sugawara Y; Kokudo N
    Liver Int; 2011 Jan; 31(1):22-35. PubMed ID: 20874725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
    Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
    Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: Association with the invasive potential.
    Hsiang CY; Wu SL; Chen JC; Lo HY; Li CC; Chiang SY; Wu HC; Ho TY
    Toxicol Lett; 2007 Jun; 171(1-2):78-86. PubMed ID: 17543481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
    Zhu B; Shi S; Ma YG; Fan F; Yao ZZ
    Hepatogastroenterology; 2012 May; 59(115):785-9. PubMed ID: 22020916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Des-gamma-carboxy prothrombin (DCP) antagonizes the effects of gefitinib on human hepatocellular carcinoma cells.
    Cui SX; Zhang YS; Chu JH; Song ZY; Qu XJ
    Cell Physiol Biochem; 2015; 35(1):201-12. PubMed ID: 25591763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.